Chinese and Western medicine for rheumatoid arthritis
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This study combines traditional Chinese medicine with Western medicine to treat rheumatoid arthritis. It aims to see how well this approach works for people with hard-to-treat RA or RA-related lung disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You need a diagnosis of rheumatoid arthritis using standard medical criteria.
- If your RA is difficult to treat, it must meet specific guidelines for hard-to-treat RA.
- If you have RA-related lung disease, both a rheumatologist and a lung doctor must confirm it.
- You must be willing to receive traditional Chinese medicine treatments.
- You cannot have serious health issues like cancer, severe lung problems, or active infections.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial combines traditional Chinese herbal medicine with standard Western treatments for people with rheumatoid arthritis that hasn't responded well to at least two prior medications. It aims to see if the combination is more effective and safe.
This study compares different treatment strategies for people with rheumatoid arthritis who also have interstitial lung disease (a type of lung scarring). It aims to find the best way to manage both conditions and potentially slow lung damage.
This study tests an investigational drug called TLL-018 for people with moderate to severe rheumatoid arthritis who have not improved enough with standard disease-modifying drugs. It aims to see if the drug can reduce joint pain and swelling.
This trial tests whether adding a traditional Chinese herbal formula to standard treatment helps people with anti-synthetase syndrome-related interstitial lung disease. It may reduce symptoms and improve lung function.
This trial tests whether adding Huoluo Pills, a traditional Chinese medicine, to the standard drug iguratimod helps reduce joint pain and swelling better than iguratimod alone. If you have mild to moderate rheumatoid arthritis, this study might offer a new option.
This study combines traditional Chinese medicine (such as acupuncture or herbal treatments) with standard Western care to help reduce knee arthritis pain. It aims to improve your comfort and ability to move, and may be an option if your current knee pain is significant and other treatments haven't helped enough.
Hear when a new Rheumatoid Arthritis-Associated Interstitial Lung Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.